Skip to main content
Premium Trial:

Request an Annual Quote

Vincent Forlenza to Become BD's Next President, CEO

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Becton Dickinson today announced that its board has elected Vincent Forlenza to take over as the company's CEO starting Oct. 1, replacing Edward Ludwig.

Forlenza who joined BD in 1980 is currently president and chief operating officer at BD. He will remain President upon becoming the firm's CEO, BD said. Starting Oct. 1, he also will become a member of the board.

Ludwig will serve as executive chairman of the board starting Oct. 1 continuing through June 2012.

The naming of Forlenza as BD's next CEO is in accordance with the company's long-term succession planning that began in 2008. In more than three decades at BD, Forlenza has worked in strategic planning, marketing, general management of several business units, and executive leadership, the company said, adding that he has served in all three of BD's business segments — BD Medical, BD Diagnostics, and BD Biosciences — as well as in strategy development and in overseas roles.

He became executive vice president in 2006, president in 2009, and COO in July 2010.

Ludwig has been CEO of BD since January 2000. Seven months before that, he was named the firm's president. In February 2002, he became chairman. During the past 12 years under his leadership, BD has more than doubled its revenues, more than tripled its net income, and almost tripled its market cap, it said. It is among the top-third in its peer group for total shareholder return during that time, BD added.

The Scan

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.

Tibetan Study Finds Adaptive Variant Influencing Skin Pigmentation

With a combination of phenotyping and genetic data, researchers document at PNAS a Tibetan-enriched enhancer variant influencing melanin synthesis and ultraviolet light response.

Domestication Linked to Nervous System Genes in Inbred Mouse Strains

Researchers highlighted more than 300 positively selected genes in domesticated mice, including genes linked to nervous system function or behavior in Genome Biology.

ALS Genetic Testing May Be Informative Across Age Ranges, Study Finds

Researchers in the journal Brain identified clinically actionable variants in a significant subset of older ALS patients, prompting them to point to the potential benefits of broader test use.